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GENERAL INTRODUCTION 
Cholera Disease 
Cholera is an acute intestinal infection, accompanied by voluminous, watery 
diarrhea, and is characterized by severe dehydration. The watery diarrhea is referred to 
as “rice-water stool” as it is similar in appearance to the leftover water after washing 
rice. Diarrhea may progress to fluid losses of up to one liter per hour (1). Other 
symptoms include vomiting, abdominal discomfort or cramping, lethargy, dry mouth, 
cold clammy skin, decreased skin turgor, and winkled hands and feet (2). Muscle 
cramping and weakness are common due to electrolyte loss. Fever is considered rare 
and may be associated with a secondary infection. In extreme cases, excessive 
diarrheal illness can lead to severe dehydration and even death.  
Rehydration is the primary treatment for patients with a cholera infection.  Oral 
rehydration solution (ORS), introduced in the late 1960s, is currently the preferred 
treatment for cholera. ORS is designed to replace previous and continuing fluid loss by 
maximizing sodium uptake in the small intestine (3, 4). The World Health Organization 
(WHO) sets strict guidelines on the various salts and glucose to be included in the ORS 
to maximize its effectiveness (5).  Antibiotics may also be added to the treatment 
regimen to decrease severity and duration of symptoms. Various findings indicate that 
antibiotics can reduce stool volume by 8-92%, shorten diarrhea duration by 50-56%, 
and decrease bacterial shedding by 26-83% (6-10). 
While cholera treatment can be quite effective, preventing an outbreak would be 
ideal. Although cholera vaccines exist, there is not yet a vaccine with long-term or 
complete protection. Currently, two oral cholera vaccines (OCV), termed Dukoral and 
Shanchol, are considered safe and effective, and are licensed and available. Both 
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vaccines contain killed whole cell V. cholerae O1. Additionally, the Dukoral vaccine 
contains recombinant cholera toxin B subunit, and the Shanchol vaccine contains V. 
cholerae O139 (11). These vaccines are estimated to be 50-85% protective for two to 
three years (12-15). The WHO highly recommends the addition OCV into the current 
cholera control program in endemic areas, however, issues including cost and delivery 
still remain (11). 
 The World Health Organization estimates there to be 1.4-4.3 million cases of 
cholera per year (16). Approximately 75% of the infected individuals will show no 
symptoms, but will typically still shed the bacteria 24 hours after infection. These 
asymptomatic carriers are still able to infect others (17, 18). Of the symptomatic 
individuals, approximately 20% will experience the intestinal infection with severe, 
watery diarrhea and dehydration. These individuals can begin to shed V. cholerae in 
their stools before the onset of symptoms (19, 20), and will continue to shed bacteria 7-
14 days after infection (21, 22). If untreated, the fatality rate for severe cholera cases is 
approximately 50% (23). However, if treated, the fatality rate drops to around 1% (24). 
Currently, there are approximately 100,000 to 120,000 deaths per year caused by 
cholera.  
 
History 
 Cholera has been around for centuries, especially in Southern Asia, but the 
causative agent was not originally known. The first written accounts of a cholera-like 
disease date back as far as 500 BC in Sanskrit (2). Initially, cholera occurred in 
epidemics around the Ganges delta region with high mortality rates. It wasn’t until 1817 
that cholera spread out of the Indian subcontinent, spanning as far as southern 
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Russian, causing its first pandemic. Filth and poor infrastructure, and the development 
of trade and transportation, allowed cholera the ability to spread and flourish (25).  The 
second pandemic started in 1826, reaching the United Kingdom by 1831 and the United 
States in 1832 (25). Since the first pandemic in 1817, there have been a total of seven 
pandemics. The current (seventh), ongoing pandemic began in 1961 in Indonesia (26). 
Cholera was originally thought to spread by an unhealthy smell or vapor, known 
as miasma. However, in 1854, London physician, John Snow, suggested that the 
disease was caused by contaminated drinking water, based on his pioneering 
epidemiological study in the Soho neighborhood of London (27). Separately, in 1854, 
Filippo Pacini observed comma-shaped objects under the microscope in stool samples 
from deceased cholera patients. He described these objects as infectious and the 
causative agent of the disease (28). However, Pacini’s publication was not widely 
recognized. It wasn’t until 1884, one year after Pacini’s death, that Robert Koch isolated 
and rediscovered the etiological agent of cholera (29), therefore receiving credit for 
many years as initially discovering Vibrio cholerae (28). In 1965, Pacini was finally 
recognized for his initial discovery of V. cholerae when the judicial commission of the 
international committee on bacteriological nomenclature officially changed the name of 
the bacteria to “Vibrio cholerae Pacini 1854,” (30). 
 
Vibrio cholerae  
 In 1884, the bacterium Vibrio cholerae was definitively determined to be the 
causative agent of the disease cholera (29). V. cholerae is a Gram-negative, curved 
rod-shaped bacterium belonging to the Vibrionaceae family. V. cholerae is classified 
into various serogroups by the O antigen lipopolysaccharide (31). There are over 200 
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serogroups (32, 33), but only the O1 and O139 serogroups cause epidemic and 
pandemic disease. The V. cholerae O1 serogroup can be further divided into two 
biotypes, classical and El Tor (23). Classical V. cholerae O1 was presumably the cause 
of the first six pandemics, while the seventh pandemic has been caused by the El Tor 
biotype. The El Tor biotype seems to have displaced the classical biotype, which 
appears to have become extinct in the environment (34). Previously, the O1 serogroup 
was thought to be the only cause of cholera, but the discovery of V. cholerae O139 in 
1992 proved to be a new cause of the disease (35-37). The V. cholerae O1 and O139 
serogroups currently coexist, but O139 was thought in the 1990s to be the cause of an 
upcoming (eighth) pandemic of cholera (23). In 2002 in Bangladesh, the number of 
cholera O139 associated cases exceeded the number of cholera El Tor associated 
cases (38). Similarly, in 2013, China reported 49 cholera cases, of which 37 were 
caused by O139, and 12 were caused by O1 (16). In recent years, the primary cause of 
cholera in most of the world has been “El Tor variant” strains, which have genomes that 
are largely similar to older El Tor strains but carry some classical genes as well. El Tor 
variants cause a more severe form of cholera than typical El Tor strains (39-41). 
 
Global Impact of Cholera 
 In 2013, 129,064 cases of cholera and 2,102 related deaths were reported to the 
WHO by 47 countries. However, it is estimated that there are 1.4-4.3 million cases of 
cholera per year with 28,000-142,000 deaths around the world (16). The significant 
under-reporting is likely caused by the presumed negative impact it would have on 
travel and trade within infected populations. Other factors potentially influencing case 
report discrepancies include surveillance system limitations, case definition 
	  	  
5	  
inconsistencies, and lack of laboratory diagnostic tools. For example, Vibrio cholerae is 
environmentally prevalent in the Ganges delta region, however, in 2013, India only 
reported 6,008 cases, about 5% of the worldwide cases. They report over 2 million 
cases per year of acute watery diarrhea, 22% of which are estimated to be caused by V. 
cholerae and not reported (42). This is an example of inconsistencies in case definition 
and diagnosis.  
 In addition to the ancestral home of cholera in southern Asia, cholera is also 
currently endemic in central Africa. During a ten-year interval, from 1995-2005, there 
was a total of 632 cholera outbreaks reported worldwide; 66% of the total cases, and 
87.6% of the fatal cases were reported from sub-Saharan Africa (43). Additionally, 
besides the cholera outbreak in Haiti in 2010 (to be discussed), Africa is experiencing 
some of the worst cholera epidemics. In 2013, 22 countries in Africa reported a total of 
56,329 cases and 1,367 cholera deaths, the highest worldwide case fatality rate at 
2.43% (16).  
 Cholera has also struck the western hemisphere, in some cases causing severe 
epidemics and many deaths. Most recently, on January 10, 2010, a massive earthquake 
struck Haiti. United Nations soldiers from Nepal were part of a group sent to Haiti to aid 
in recovery from this earthquake. However, apparently one or more of these soldiers 
was actively infected with cholerae, and due to inadequate sanitation, the infected stool 
leaked into the Artibonite River, resulting in a significant cholera outbreak (44-47). Haiti 
has not been previously exposed to cholera in at least 100 years and therefore had a 
naïve and susceptible population (48). The first case of Vibrio cholerae O1 El Tor in 
Haiti was reported on October 21, 2010, near the Nepali U.N. base (47). Within one 
week, a total of 4,722 cases and 303 deaths had been reported (49). Twenty-nine days 
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after the first reported case, V. cholerae had reached all 10 administrative departments 
(states) of Haiti. Various international pubic health organizations came together to help 
in the efforts to minimize damage, including the Ministry of Public Health and 
Population, the Pan American Health Organization and the Centers for Disease Control 
and Prevention (50). The Pan American Health Organization stated emphasis of the 
response would be on “1) minimizing mortality by using oral rehydration for most cases 
and intravenous rehydration for severely ill patients and 2) preventing infection by 
promoting water treatment, adequate sanitation and hygiene, and safe food 
preparation,” (51). Despite these efforts, in October 2012, two years after the first case, 
Haiti reported a total of 604,634 cases of cholera and 7,436 deaths since the origin of 
the epidemic (52). In 2013, Haiti continued to report a significant number of cholera 
cases, 60,763, 43.7% of the worldwide cases (16). Cholera is currently endemic in Haiti 
and significant numbers of cholera patients continue to be admitted to clinics each 
month. 
 
Vibrio cholerae Life Cycle 
 Vibrio cholerae is naturally found in aquatic environments, such as freshwater 
ponds and rivers, and estuaries and brackish waters (53-55), where it can form 
commensal relationships with shellfish, copepods (crustaceans), algae, chironomid 
eggs masses, and can associate with various surfaces, forming biofilms (56-62). 
Associating with copepods and egg masses, as well as being able to form biofilms, is 
assumed to be a protective mechanism V. cholerae uses in potentially harsh 
environments. Being able to form biofilms allows the bacterial cells to persist between 
epidemic periods. V. cholerae also has the ability to switch to a viable, but non-
	  	  
7	  
culturable state, during times of nutrient deprivation (63, 64). This is another survival 
strategy in which V. cholerae can persist in poor environmental conditions and can still 
infect a host.  
V. cholerae has also been shown to be associated with various aquatic birds, 
such as pelicans, herons, gulls, and geese (65-67), within their fecal matter as well as 
externally attached to their feet and feathers (66, 68). Vertebrate fish have also recently 
been described as environmental reservoirs for V. cholerae (69-71). It has been 
suggested that V. cholerae, uses fish as a vector, both for increasing bacteria 
population and for transportation over longer distances. It is therefore hypothesized that 
fish and aquatic birds could be possible disseminators of V. cholerae between different 
bodies of water (72). 
These organisms, from shellfish to copepods, are considered to be 
environmental reservoirs for V. cholerae. Environmental reservoirs are defined as 
“location out of the human body within the niche favouring bacterial persistence and 
replication in the environment and pathogen transmission susceptible host,” (73). 
Organisms, other than humans, such as adult chironomids (flying insects), fish, and 
aquatic birds, are considered to be hosts, in which a host is defined as “a living 
organism that temporarily harbours the pathogen, generally providing nourishment and 
shelter,” (73).  
V. cholerae can dissociate from these various reservoirs and be ingested by 
humans in the form of contaminated water. It can also remain associated with 
environmental hosts and reservoirs, such as shellfish, which can then be ingested by 
humans as contaminated food. Humans are typically the only host of V. cholerae to get 
the disease cholera. However, a very high infectious dose, around 106 to 1011 bacteria, 
	  	  
8	  
is required (22). In the environment and during early stages of infection, motility and 
chemotaxis genes are highly expressed. Once ingested by humans, V. cholerae uses 
the expression of these genes to pass through the acidity of the stomach and bile from 
the duodenum, both of which are toxic to the bacteria (74, 75). V. cholerae is able to 
pass through the stomach and into the small intestine where it colonizes the surface of 
the epithelium in the intestinal crypts and villi surfaces (76-78). To colonize successfully, 
V. cholerae must downregulate motility, and upregulate virulence gene expression, 
which results in production of colonization factors (74, 75). Symptoms, as previously 
described, typically result 12-72 hours after initial colonization (17). Through either 
vomiting or diarrhea, an infected individual can shed hyperinfectious V. cholerae back 
into the environment (79). The recently shed V. cholerae remain in this hyperinfectious 
state for at least 5 hours after reentering the aquatic environment. This appears to be an 
effective way to enhance transmission in heavily crowded areas where it is likely 
another person can come in contact with the bacterium and substantially fewer bacterial 
cells are required to cause an infection (79, 80). 
Once back in the aquatic environment, V. cholerae exists in two states: free-
swimming planktonic cells or fixed cells attached to various surfaces (57, 58, 60, 81). As 
a planktonic cell, V. cholerae can persist in the previously mentioned viable, but non-
culturable state (64). These cells cannot be cultured on standard media, but still perform 
basic metabolic processes, such as protein synthesis (82), and are still able to infect a 
host, and therefore are able to regain the ability to multiply (83). Other V. cholerae cells, 
associated with various organisms, such as crustaceans, and attached to surfaces 
forming biofilms, can use chitin as a carbon and nitrogen source for survival (84-87). 
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V. cholerae Pathogenesis Genes 
 In order for V. cholerae to initiate disease, it must produce two main virulence 
factors: cholera toxin (CT) and toxin co-regulated pilus (TCP). These genes are located 
on the mobile genetic elements cholera toxin bacteriophage (CTXφ) and the Vibrio 
pathogenicity island (VPI), respectively (88-90). The CTXφ	   is found in all pandemic 
environmental isolates of V. cholerae, but is rarely found in non-O1/O139 strains (91). 
Besides CT, the CTXφ also encodes other accessory toxins, but the role of these toxins 
in pathogenesis is not well defined (92-94). Along with TCP, the VPI encodes various 
accessory virulence factors; however, much like the accessory toxins, the role these 
factors play in pathogenesis remains unclear (95, 96).  
CT, essential for cholera symptoms, disrupts ion transport by the intestinal 
epithelial cells, leading to water and electrolyte loss, and consequently, severe diarrhea. 
CT consists of five smaller B subunits, responsible for binding the toxin to the target, the 
GM1 ganglioside receptor, and one larger A subunit, which enzymatically acts to change 
the small intestine to a secreting organ instead of an absorptive one (97, 98). Ultimately, 
once inside the host cell, the A subunit causes an increase in cAMP, leading to 
secretion of chloride ions and decreased sodium uptake (99, 100). This ion imbalance 
causes massive secretion of water from the cells lining the lumen of the intestine (101, 
102). This fluid accumulation in the intestine is the source of the characteristic watery 
diarrhea associated with the disease cholera.  
TCP, a type IV bundle-forming pilus, is required for colonization in both animal 
models and human volunteers (89, 96, 103, 104). TCP is coordinately regulated with 
CT, therefore leading to the term “toxin co-regulated” (88, 89). The exact role TCP plays 
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in colonization is not yet known, however, it has been shown to mediate microcolony 
formation via pilus-mediated bacterial interaction on the surface of epithelial cells (104). 
Without TCP, V. cholerae is unable to colonize the small intestine in healthy human 
volunteers (103), therefore confirming TCP is required for colonization and disease.  
 
Motility and Chemotaxis 
 The roles of motility and chemotaxis in Vibrio cholerae colonization of the human 
gut remain unclear; different strains, mutations, and animal models can show 
contradictory results (105-109). As previously stated, V. cholerae is highly motile, with a 
single, polar, sheathed flagellum. Flagella are cell surface organelles designed for 
locomotion. Bacterial flagella consist of the basal body, the flagellar hook, and the 
flagellar filament (110). The flagellar hook attaches the actual filament to the basal 
body. The basal body, positioned within the cell envelope, functions as the rotary motor 
driven by ions, specifically Na+, moving across the membrane (111-115). However, 
flagellar assembly is dependent upon external Na+ levels (116). If Na+ concentrations 
surrounding the cell decrease, the basal body will disassemble. The reason behind this 
physiological occurrence is not yet known. 
When there are adequate levels of Na+ surrounding a cell, the assembly of the 
flagellum, including the basal body, flagellar hook, and flagellar filament, is successful.  
The basal body consists of two parts: the stator and the rotor. The basic structure of the 
V. cholerae flagellar base is shown schematically in Figure 1. The stator, or stationary 
portion, includes MotA and MotB and functions as the sodium driven motor. As ions 
pass through the MotA/MotB complex, the stator coupled to the rotor creates torque. 
The rotor, or rotary portion, contains various rings that extend through multiple 
	  	  
11	  
membranes and are connected by the proximal rod, which attaches to the hook. These 
rings have diverse functions. The C ring, composed of FliG, FliM and FliN, also 
considered the switch complex, is the main trigger for directional switch of flagellar 
rotation. The MS ring, P ring, and L ring, located in the cytoplasmic membrane, 
peptidoglycan layer, and outer membrane respectively (115, 117), do not rotate but 
function as bushing around the proximal rod of the flagellum. Lastly, the T ring, which 
surrounds the periplasmic side of the P ring (118), consists of MotX and MotY, which 
are thought to stabilize the stator surrounding the rotor, and are considered to be 
essential for motor function (118-121).  
 V. cholerae uses its flagellum for motility and chemotaxis to move through a host 
toward a prime site of colonization. In general, chemotaxis is the ability of bacteria to 
move with or against a chemical gradient.  This process in V. cholerae is very complex 
with three chemotaxis operons, 68 open reading frames (ORF), and multiple gene 
duplications. Only one of the three operons is said to be essential for chemotaxis (122, 
123).  Of the 68 ORFs, 46 are believed to encode possible methyl-accepting 
chemotaxis proteins (MCP), and 22 are homologues for che genes, including five cheY, 
three cheA, three cheB, and two cheW gene duplications (124). MCPs are the proteins 
that sense the chemical signals from outside of the cell and trigger downstream 
chemotactic and motility effects. With so many MCPs, V. cholerae has the ability to 
travel toward and away from many signals. The complexity of this system is presumably 
because V. cholerae needs to be able to survive in many different aquatic 
environments.  
 Chemotaxis in V. cholerae (diagramed in Figure 2) is initiated when a MCP 
senses a chemical attractant or repellent outside of the cell. The MCP signals the 
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sensor kinase, CheA, to autophosphorylate. CheA, associated with cytoplasmic linker 
protein CheW, can then transfer the phosphate to three different proteins. Two 
mechanisms of negative feedback include the phosphate being transferred to either 
CheB or CheV. Phosphorylated CheB causes demethylation of the MCP, therefore 
ceasing signal output, and phosphorylated CheV prevents the signal from the MCP from 
reaching CheA. CheA can also transfer its phosphate to CheY, the response regulator. 
CheY then triggers the C ring, specifically FliM, to switch flagellar rotation. The C ring 
then signals the motor, composed of MotA and MotB, to switch direction. Very little is 
known about how CheY signals the C ring, and how the C ring signals the motor.  
 Many studies on the roles of motility and chemotaxis in host colonization have 
been performed with contradictory results. In one study, various chemotaxis genes from 
the El Tor biotype were deleted and colonization in the infant mouse model was 
measured. Multiple V. cholerae non-chemotactic mutants actually hypercolonized the 
infant mouse intestine (125). This same study reported that a non-chemotactic mutant 
colonized the entire length of the intestine, whereas the wild-type strain was localized to 
the distal portion of the infant mouse intestine (125), suggesting V. cholerae uses 
chemotaxis to find a preferred site of colonization. It has also been suggested by Freter 
et. al. (107, 108) that non-chemotactic mutants likely lack the ability to enter the 
intestinal crypts, and therefore are not killed by the innate immune system. 
Consequently, it is assumed non-chemotactic V. cholerae outcompeting wild-type in 
intestinal colonization is due to the fact that it is avoiding killing by the immune system.  
In another study, various chemotaxis and motility mutants from the classical and 
El Tor biotypes were tested for colonization in three separate animal models (109). 
There were varying results between the different strains and models. Richardson (109) 
	  	  
13	  
also proposed that motility likely increases the number of interactions between the 
bacterium and intestinal epithelium. In addition to motility, chemotactic responses can 
also enhance the number of interactions. Ultimately, this study concluded that motility is 
indeed a major factor contributing to pathogenicity and colonization. 
 
Zebrafish and Other Models 
 Various model organisms have been used to demonstrate Vibrio cholerae 
colonization, infection and pathogenesis. Common mammalian animal models include 
the suckling mouse model (126, 127), and the rabbit ligated ileal loop and the 
removable intestinal tie-adult rabbit diarrhea (RITARD) models (128-130). However, 
these animal models are not natural hosts for V. cholerae infection. The suckling mouse 
does not demonstrate signs of pathogenesis and the adult rabbits develop a disease 
unlike that of the human cholera infection. Adult rabbits also required various 
manipulations including a clearing of the intestinal microbiota and survival surgery. 
However, a new model for V. cholerae colonization has been recently described.  
 The adult zebrafish has been described as a natural host model for V. cholerae 
colonization (70). Zebrafish become colonized naturally, with no manipulation. 
According to a previous study, V. cholerae was found colonizing the intestines of 10 
different wild-caught fish species in Israel (69). Another study found that between 10% 
and 17% of tilapia were colonized by V. cholerae during the warm season in Burkina 
Faso (71). This suggests that V. cholerae may use vertebrate fish as both a vector for 
transport to various locations, as well as a reservoir to increase bacterial population.  
 The zebrafish intestine consists of one long tube that folds over twice in the 
abdomen connecting the esophagus to the anus. Zebrafish do not have an acidified 
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stomach and there is no distinction between the small and large intestine. However, 
variances in morphologies throughout the intestine suggest a functional differentiation. 
The morphology of the mucosal columnar epithelial cells and increasing number of 
goblet cells support this idea (131). Also, progressing from rostral-to-caudal direction, 
the tube narrows and mini folds within the lumen become progressively shorter. These 
mini folds are significantly larger than the microvilli within a mammal intestine (132). 
However, a study by Runft et. al. (70) presented data where wild-type V. cholerae was 
able to reach and presumably colonize within these intestinal folds in the zebrafish 
intestine. 
 
 The goal of this work is to better understand how motility and chemotaxis effect 
Vibrio cholerae colonization in a rather new model, the zebrafish. Zebrafish are 
suggested to be a natural host to V. cholerae as they become colonized with no 
manipulation. Although extensively studied in other animal models regarding their role in 
pathogenesis, not much is certain about how chemotaxis and motility effect colonization 
and disease. A list of strains used in this work is included in Table 1. This thesis 
characterizes the roles various chemotaxis and motility genes play in colonization in the 
zebrafish model.  
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FIGURE 1. Flagellar structure. The flagellar basal body consists of two main parts, the 
stator and the rotor. The stator, or stationary portion, included MotA and MotB and 
function as the sodium driven motor. The rotor, or rotary portion, includes the L ring, P 
ring, and MS ring, located in the outer membrane, peptidoglycan layer, and cytoplasmic 
membrane respectively. These rings do not rotate, but act as bushing around the 
proximal rod. The rotor also includes the C ring, which is responsible for directional 
switch of the flagellum. Lastly, the T ring, surrounding the periplasmic side of the P ring, 
is thought to stabilize the stator around the rotor.  
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FIGURE 2. Chemotaxis in Vibrio cholerae. Chemotaxis is initiated when a methyl-
accepting chemotaxis protein (MCP), senses a chemical single, a chemoattractant or 
chemorepellent, from outside the cell. The MCP signals the sensor kinase, CheA, 
associated with cytoplasmic linker protein CheW, to autophosphorylate. CheA can 
negatively regulate chemotaxis by transferring its phosphate to either CheB, which 
demethylates the MCP, or to CheV, which inhibits to MCP signal from reaching CheA. 
CheA can also transfer its phosphate to CheY, the response regulator. CheY then 
signals the C ring to switch flagellar rotation.The C ring then signals the motor, 
composed of MotA and MotB, to switch direction.  
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Strain Description Parent Strain Source  
 
JW 514 
 
Vibrio cholerae El Tor 
strain N16961 
 
Lab Collection 
 
JW 1868 
 
ΔcheY-3 
 
JW 514 
 
This Work 
 
JW 1870 
 
ΔflaA 
 
JW 514 
 
This Work 
 
JW 1878 
 
ΔcheY-4 
 
JW 514 
 
This Work 
 
JW 1898 
 
ΔmotA 
 
JW 514 
 
This Work 
 
JW 1893 
 
ΔmotB 
 
JW 514 
 
This Work 
 
JW 1904 
 
ΔmotAB 
 
JW 514 
 
This Work 
 
JW 1890 
 
ΔcheA-2 
 
JW 514 
 
This Work 
 
JW 1892 
 
 
ΔmotY 
 
JW 514 
 
This Work 
JW 75 E. coli SM10 λpir  Lab Collection 
 
Table 1. List of strains used in this work. 
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CHAPTER ONE 
The effects of motility and chemotaxis on Vibrio cholerae colonization in zebrafish 
 
ABSTRACT 
 Vibrio cholerae, the causative agent of the diarrheal disease cholera, is a gram-
negative, curved rod-shaped bacterium, with a single polar flagellum. V. cholerae is 
naturally found in aquatic environments and is highly motile. When it enters a human 
host, V. cholerae uses flagellar motility and chemotaxis to pass through the stomach 
and into the small intestine. Once in the small intestine, motility genes are 
downregulated and virulence gene expression is upregulated. V. cholerae motility and 
chemotaxis effects have not yet been studied in a zebrafish model, a natural host of this 
bacterium. We have predicted that V. cholerae in frame deletions of vital motility and 
chemotaxis genes, such as flaA, cheY-3, and motY, would decrease the ability of V. 
cholerae to colonize the zebrafish intestine. However, we find instead that the deletion 
of chemotaxis gene cheY-3, actually significantly increases the ability of V. cholerae to 
colonize the zebrafish intestine, and only the deletion of motility gene motY decreases 
the ability of V. cholerae to colonize. 
 
INTRODUCTION 
 The disease cholera is characterized as an intestinal infection, accompanied by 
voluminous, watery diarrhea, leading to severe dehydration and even death. The 
bacterium responsible for this disease, Vibrio cholerae, is a gram-negative curved rod-
shaped bacterium with and single polar flagellum. V. cholerae is highly motile and uses 
this ability, along with chemotaxis, to navigate through a host, and toward a prime site of 
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colonization. Although extensively studied in their roles in regard to pathogenesis, little 
is known about the effects motility and chemotaxis have on colonization. To further 
characterized their importance, we selected various chemotaxis and motility genes to 
delete from the V. cholerae El Tor biotype N16961. These deletion mutants include 
ΔcheY-3, ΔcheY-4, ΔcheA-2, ΔflaA, ΔmotA, ΔmotB, ΔmotAB, and ΔmotY. The reason 
for selection of these specific genes is described below. 
Chemotaxis in Vibrio cholerae is a very complex process, so we wanted to select 
some genes that are thought to be key players in this system. Based on previous 
studies on chemotaxis, we chose to focus on cheY-3, cheY-4, and cheA-2. According to 
sequence analysis, of the five cheY homologues in V. cholerae, cheY-3 is most similar 
to the E. coli CheY protein (124). Also, a cheY-3 transposon insertion mutant has been 
reported as being non-chemotactic as seen on swarm plate analysis (125). It has also 
been stated that only V. cholerae cheY-3, and not cheY-1, cheY-2, or cheY-4, can affect 
flagellar rotation, and only a cheY-3 deletion shows this chemotaxis defect (124, 133, 
134). That being said, we also chose to delete cheY-4 because it is suggested to be 
involved in attachment to host cells and migration towards the intestine (134). CheY-4 is 
also thought to modulate chemotaxis indirectly by regulating the expression of other 
unknown factors (134). Our third chemotaxis target was cheA-2, the presumed sensor 
kinase responsible for receiving the signal from the MCP and in turn initiating 
chemotaxis.  Of the three cheA homologues, only cheA-2 is thought to be essential for 
chemotaxis (123). A cheA-2 transposon insertion mutant is show to be non-chemotactic 
(124), and the V. cholerae cheA-2 gene actually encodes a functional homologue of the 
E. coli CheA protein (123). We hypothesized that V. cholerae mutants deficient in 
chemotaxis would have decreased colonization in the zebrafish compared to wild-type.  
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We also created four Vibrio cholerae motility mutants, ΔmotA, ΔmotB, ΔmotAB, 
and ΔmotY, and a flagellin mutant, ΔflaA. The flaA deletion is non-motile and non-
chemotactic (125). V. cholerae has five flagellin genes, flaA-E, however, flaB-E are not 
essential for flagellar synthesis and only a mutation in flaA results in the motility defect 
(135). Based on an electron micrograph from a previous study, we can assume our flaA 
deletion mutant does not have a flagellum (125). We also generated four mutants, 
ΔmotA, ΔmotB, ΔmotAB, and ΔmotY, with flagellar motor defects. MotA and MotB 
function as the sodium-driven rotary motor, therefore, deletions in these genes result in 
a non-functioning or non-existent flagellar motor. MotY is considered to be essential for 
motor function (136), and is thought to stabilize the motor around the rotor (118-121). 
We hypothesize that non-motile V. cholerae mutants would colonize the zebrafish less 
than wild-type. 
 In this study we characterized the effects various Vibrio cholerae chemotaxis and 
motility genes have on colonization in the zebrafish. We report that deletion of cheY-3, 
rendering V. cholerae motile but non-chemotactic, significantly increases colonization 
levels compared to wild-type. However, deletion of other chemotaxis genes, such as 
cheY-4 and cheA-2, does not significantly alter colonization levels. We also show that 
deletion of motY, rendering V. cholerae non-motile, significantly decreases colonization 
levels in the zebrafish intestine. However, deletion of other motility genes, such as motA 
and motB, does not significantly alter colonization levels. Deletion of the flagellum, flaA, 
from V. cholerae also does not significantly change colonization levels compared to 
wild-type.  
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MATERIALS AND METHODS 
 V. cholerae strains and growth conditions. All V. cholerae strains used in this 
study are derived from the El Tor biotype N16961 and are listed in Table 1. Strains were 
maintained in LB (Luria Broth) containing 20% glycerol and stored at -70°C. Overnight 
cultures were grown in LB with an antibiotic concentration of 100 µl/ml streptomycin for 
approximately 16 hours shaking at 37°C.  
 Strain construction. All V. cholerae mutants in this work were created with in-
frame deletions of the various genes. Site-directed deletion mutants were completed 
using splicing by overlap extension PCR (137). PCR products, with specific restriction 
enzymes, were inserted into suicide vector, pKAS32, carrying an ampicillin resistance 
marker. The plasmid was then transformed into E. coli SM10 λpir and subsequently 
mated with V. cholerae N16961. Mated cultures were plated on V. cholerae selective 
TCBS plates and then hi-strep (1 mg/ml streptomycin) LB plates. Deletions were 
confirmed using PCR.  
 V. cholerae motility analysis and chemotactic swarm assay. Bacterial cell 
motility was determined by visualizing 5 µl of overnight or sub-culture under a light 
microscope and determining motile or non-motile based on observed swimming. To 
measure chemotactic ability, swarm agar plates (1% tryptone, 0.5% NaCl, 0.3% agar) 
were spot inoculated with 1 µl of normalized overnight cultures of wild-type or mutant 
strains of V. cholerae. The plates were incubated at room temperature for 24 hours and 
measured for swarm diameter.  
 Zebrafish. Experiments were performed using six to nine month old ZDR wild-
type zebrafish. The zebrafish were euthanized in 100 ml of a double dose (336 µl/ml) of 
Tricaine (ethyl-3 aminobenzoate methanesulfonate salt; catalog no. A50040; Sigma) 
	  	  
22	  
solution. The fish remained in the solution for 25-30 minutes. Zebrafish were infected 
and dissected as described below. All animal protocols were approved by the Wayne 
State University IACUC committee.  
Inoculation of Zebrafish via water. Bacterial cultures were washed twice in 
phosphate-buffered saline (PBS) and re-suspended to the correct concentration using 
PBS. Cultures were washed by centrifugation and re-suspension unless otherwise 
noted. Prior to adding the bacterial cultures to the fish water, four to five zebrafish were 
placed in a 400 ml beaker with a perforated lid containing 200 ml of tank water 
(sterilized ddH2O with 60 mg/liter of Instant Ocean aquarium salts [138]). One milliliter of 
bacterial inoculum with concentrations ranging from 108 to 109 CFU per beaker (5x105-6 
CFU/ml) was added to the fish infection beakers. Each beaker was placed in a glass 
front incubator set at 27°C for the duration of the experiment.  
Several experiments included the addition of a wash step of the fish between four 
and six hours post infection. Fish infection beakers were drained of water, and fresh 200 
ml of tank water was added. Fish were allowed to swim for five minutes before this 
wash was repeated. Lastly, fish infection beakers were again drained of their water, and 
fish were transferred to fresh beakers with fresh 200 ml of tank water. Beakers were 
then returned to the incubator for the reminder of the experiment.  
Determination of V. cholerae colonization in zebrafish intestine. At 24 hours 
post infection, fish were removed from the beakers and euthanized as described above. 
Intestines were aseptically removed, placed in 900 µl of LB containing 1 mm glass 
beads, and homogenized using a mini-beadbeater, in three pulses for 1 minute, with a 2 
minute-on ice-intemittent period. Serial dilutions of the homogenate were performed and 
plated onto selective media for enumeration.  
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RESULTS 
 All mutant strains have decreased chemotaxis compared to wild type. To 
ultimately test the effects chemotaxis and motility have on colonization in the zebrafish 
model, we created mutants that exhibited various defects in these areas. Mutants were 
constructed from parental strain V. cholerae El Tor N16961. In frame deletions were 
executed for the following genes: cheY-3, cheY-4, cheA-2, motA, motB, motAB, motY, 
and flaA. Overnight and sub-cultures of the mutants were visualized using light 
microscopy and determined to be either motile or non-motile compared to wild-type by 
observed swimming. Non-motile mutants included ΔmotA, ΔmotB, ΔmotAB, ΔmotY, and 
ΔflaA. Mutants with motility similar to wild-type levels include ΔcheY-3, ΔcheY-4, and 
ΔcheA-2.  
All mutant strains were also tested on swarm agar to quantify chemotactic 
properties. Bacterial cultures were inoculated into swarm plates as described above, 
and incubated overnight at room temperature. Plates were photographed (Figure 3a) 
and swarm diameter was measured (Figure 3b). All V. cholerae chemotaxis and motility 
mutants (average diameters of 1.5 mm to 12.5 mm) showed significantly less swarm 
diameter than wild-type (average 15.5 mm). Our results support those from a previous 
swarm plate analysis study (125) where cheY-3 and cheA-2 transposon insertion 
mutants rendered the bacteria non-chemotactic and in-frame deletions of flagellar motor 
genes, motAB and motY, and flagellin gene, flaA, generated mutants that are non-
motile. 
 Deletion of cheY-3 leads to significantly increased colonization in 
zebrafish. V. cholerae presumably uses chemotaxis to move through a host to the 
prime site of colonization, and therefore, chemotaxis is assumed to be essential for 
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colonization and disease. In this study, a non-chemotactic V. cholerae mutant, ΔcheY-3, 
was able to colonize the zebrafish intestine to levels significantly higher than wild-type 
(Figure 4). Our study corresponds to a previous study where a cheY-3 transposon 
insertion mutant, and a cheY-3 deletion mutant were able to outcompete wild-type V. 
cholerae in the infant mouse model (140).  
 Other V. cholerae chemotaxis mutants do not show the same increased 
colonization in the zebrafish as our ΔcheY-3 mutant. Our results of the cheY-4 deletion 
show no significant colonization differences in zebrafish compared to wild-type (Figure 
5A-C). This result supports previous findings suggesting cheY-4 does not affect 
chemotaxis (134). Our result of the cheA-2 deletion also shows no significant 
colonization differences in the zebrafish compared to wild-type V. cholerae (Figure 5A-
C). These mutants, ΔcheY-4 and ΔcheA-2, were tested in the zebrafish using three 
different procedures. The results shown in Figure 5A and Figure 5B were performed 
using procedures described previously. The third set of results (Figure 5C) was 
performed by washing the bacteria by vacuum filtration instead of centrifugation prior to 
infection. Previous studies have shown that high-speed centrifugation can actually alter 
the bacterial cell surface and the viability of the organism (141-142). Through 
preliminary testing, and visualization using light microscopy, we determined that 
centrifuged bacterial cells exhibited decreased motility compared to vacuum filtered 
cultures. Vacuum filtration was then tested to see if there was a difference in 
colonization by possible bacterial damage during high-speed centrifugation. Ultimately, 
vacuum filtration compared to centrifugation appeared to not alter colonization levels in 
the zebrafish model, and therefore, we concluded that there were not significant 
differences between procedures (Figure 5A-C). 
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 Deletion of motY leads to significantly decreased colonization in zebrafish. 
Motility of V. cholerae is considered to be a major factor contributing to pathogenesis 
and colonization.  In human infection, V. cholerae uses motility to pass through the 
stomach and into the small intestine, where it colonizes. Although the anatomy of 
zebrafish and humans is quite different, we assumed V. cholerae would use motility to 
navigate through the zebrafish intestinal tract. Our results show, that a V. cholerae motY 
deletion mutant colonizes significantly less than wild-type (Figure 5A). The other results 
for ΔmotY infections (Figure 5B, C), using the alternate infection procedures, do not 
show this difference. It is possible more replications using these procedures are needed 
for more definitive results. 
 While the motY deletion mutant colonizes significantly less than wild-type in the 
zebrafish model, other deletions affecting motility do not alter colonization. We show 
that deletions disabling the flagellar motor, ΔmotA, ΔmotB, and ΔmotAB, do not 
colonize significantly differently from wild-type V. cholerae (Figure 6). While there do 
appear to be differences in colonization, these variances are not significant. Our study 
also indicates that deletion of the V. cholerae flagellar filament, flaA, does not result in 
colonization levels different than wild-type (Figure 4). 
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DISCUSSION 
 Our findings indicate that while all of the mutants show significantly decreased 
swarm diameters compared to wild-type, only a few mutants show significantly altered 
colonization differences in the zebrafish. Non-motile Vibrio cholerae, including ΔflaA, 
ΔmotA, ΔmotB, and ΔmotAB mutants, have no significant defect in colonization. Even 
with deletion of the flagellum and deletion of the flagellar motor, V. cholerae still has the 
ability to enter and colonize the zebrafish intestine. This could be due to the fact that V. 
cholerae and the zebrafish are placed within a confined space. While, the mutant V. 
cholerae cannot swim, the zebrafish are continually moving and stirring up the water. 
We can assume that while swimming, the fish come in contact with and ingest many V. 
cholerae bacterial cells. The V. cholerae cells do not appear to need to swim to reach 
the zebrafish intestine.  
We have also shown that various chemotaxis mutants, including the cheY-4 and 
cheA-2 deletions, do not colonize significantly differently from wild-type V. cholerae in 
the zebrafish model. It is possible that the other cheA homologues can compensate for 
the cheA-2 deletion. Furthermore, cheY-4 has previously been stated as appearing to 
not have an effect on chemotaxis (139). Unlike CheY-3, CheY-4 cannot bind the C ring 
to switch flagellar rotation (139). CheY-4 could however pull the phosphate from CheY-
3. A study by Hyakutake et. al. (134) suggests that CheY-4 could regulate the 
expression of certain factors that in turn modulate chemotaxis indirectly. Our results can 
neither confirm nor deny these suggestions.  
 Some V. cholerae genes however, do appear to affect colonization within the 
zebrafish model. The deletion of cheY-3 for example, surprisingly shows a significant 
increase in colonization in the zebrafish compared to wild-type V. cholerae, while the 
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deletion of motY shows a significant decrease in colonization compared to wild-type. 
The motY deletion was the only non-motile mutant to appear to significantly impact 
colonization in the zebrafish. It is unclear why one non-motile mutant colonized 
significantly less than wild-type when the others, ΔflaA, ΔmotA, ΔmotB, and ΔmotAB, 
demonstrated no significant difference.  
As stated, one of our chemotaxis mutants, the V. cholerae cheY-3 deletion, 
colonized to significantly higher levels than wild-type in the zebrafish model. As 
chemotaxis is defined as the ability of an organism to move toward or away from a 
chemical signal, in our model, chemotaxis is presumably the ability of V. cholerae to 
move toward a desired site of colonization. Without the ability to do this, we assumed 
that a non-chemotactic mutant would show decreased colonization levels. This is, 
however, not the case in the zebrafish model. A non-chemotactic V. cholerae cheY-3 
deletion mutant colonizes significantly higher than wild-type in the zebrafish model. 
There are a couple of explanations to describe why this is the case. It is possible that 
the non-chemotactic V. cholerae cannot get within the intestinal folds of the zebrafish 
intestine, cannot reach the intestinal epithelial cells and therefore, cannot be fought off 
by the immune system. This has been previously postulated to be the case in mice 
(107, 108).  Another possibility for this colonization increase could be that the mutant V. 
cholerae are unable to chemotax to the prime site of colonization, and therefore, the 
bacterial cells colonize the entire length of the fish intestine. In the human gut, V. 
cholerae is known to colonize the upper small intestine. While zebrafish do not have 
distinct large and small intestines, there do appear to be differences in morphologies, 
suggesting a functional differentiation throughout the intestine. Experiments comparing 
rostral and distal colonization in the zebrafish have not yet been performed. However, 
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Lee et al. (125), did find that a V. cholerae cheY-3 transposon insertion mutant was able 
to colonize the entire length of the small intestine of infant mice, where wild-type V. 
cholerae primarily colonized the lower small intestine.  
This study is meant to characterize the effects of chemotaxis and motility on 
colonization in the zebrafish model. Since vertebrate fish have been proposed as a 
natural host for Vibrio cholerae we hope these findings can shed some light on the 
importance of motility in the V. cholerae life cycle. Within a confined space, V. cholerae 
does not necessarily need all genes associated with chemotaxis and motility to colonize 
a natural host, like the zebrafish, successfully. However, this may not be true when V. 
cholerae is in its natural aquatic environment, such as a freshwater pond or river. 
Although V. cholerae chemotaxis and motility are stated as important in pathogenesis, 
the direct effects they have on colonization in the human intestine remain unknown. 
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FIGURE 3. Motility and chemotaxis in semisolid agar. (A). Chemotactic ability of each 
mutant was determined by stabbing overnight cultures of cells into swarm plates. Strain 
genetic backgrounds are indicated by each swarm location. Assay was performed in 
triplicate, two plates are not shown. (B). Swarm diameters were measured in triplicate 
and compared to wild-type. Statistical significance was determined by one-way ANOVA, 
*** (p<0.001). 
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FIGURE 4. Zebrafish colonization assay: wild-type Vibrio cholerae, and ΔcheY-3 and 
ΔflaA mutants. V. cholerae ΔcheY-3 mutant colonizes significant higher that wild-type in 
the zebrafish model. Each symbol represents the data from one zebrafish. Statistical 
significance was determined by one-way ANOVA, * (p<0.05). Values are normalized to 
WT as follows:	   cfu /mlWTcfu /mlmut!"# $%&cfu / intestinemut  
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FIGURE 5. Zebrafish colonization assays: wild-type Vibrio cholerae, and ΔcheY-4, 
ΔcheA-2, and ΔmotY mutants. (A) V. cholerae ΔmotY mutant colonizes significant lower 
that wild-type in the zebrafish model. (B) Infections were performed with the wash step 
of the fish. Mutants do not colonize significantly differently than wild-type. (C) Prior to 
fish infections, bacterial cultures were washed by vacuum filtration, not centrifugation. 
Mutants do not colonize significantly differently from wild-type. Each symbol represents 
the data from one zebrafish. Values are normalized to WT as previously stated. 
Statistical significance was determined by one-way ANOVA, * (p<0.05). 
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FIGURE 6. Zebrafish colonization assay: wild-type Vibrio cholerae, and ΔmotA, ΔmotB 
and ΔmotAB mutants. Infections were performed with the wash of the fish. Mutants do 
not colonize significantly different than wild-type. Each symbol represents the data from 
one zebrafish. Values are normalized to WT as previously stated. 
 
  
	  	  
33	  
REFERENCES 
1. Phillips RA. 1964. Water and electrolyte losses in cholera. Fed Proc 23:705-
712. 
2. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. 2012. Cholera. 
Lancet 379:2466-2476. 
3. Guerrant RL, Carneiro-Filho BA, Dillingham RA. 2003. Cholera, diarrhea, and 
oral rehydration therapy: triumph and indictment. Clin Infect Dis 37:398-405. 
4. Nalin DR, Cash RA, Islam R, Molla M, Phillips RA. 1968. Oral maintenance 
therapy for cholera in adults. Lancet 2:370-373. 
5. WHO. 2006. Oral Rehydration Salts: Production of the New ORS. WHO, 
Geneva.  
6. Greenough WB, Gordon RS, Rosenberg IS, Davies BI, Benenson AS. 1964. 
Tetracycline in the treatment of cholera. Lancet 1(7329):355-357. 
7. Lindenbaum J, Greenhough WB, Islam MR. 1967. Antibiotic therapy of 
cholera. World Health Organ 36:871-883. 
8. Rahaman MM, Majid MA, Alam AKMJ, Islam MR. 1976. Effects of doxycycline 
in actively purging cholera patients: a double-blind clinical trial. Antimicrob 
Agents Ch 10(4):610-612. 
9. Roy SK, Islam A, Ali R, Islam KE, Khan RA, Ara SH, Saifuddin NM, Fuchs 
GJ. 1998. A randomized clinical trial to compare the efficacy of erythromycin, 
ampicillin and tetracycline for the treatment of cholera in children. T Roy Soc 
Trop Med H 92:460-462. 
	  	  
34	  
10. Kaushik JS, Gupta P, Faridi MMA, Das S. 2010. Single dose azithromycin 
versus ciprofloxacin for cholera in children: a randomized controlled trial. Indian 
Pediatr 47:309-315. 
11. World Health Organization (WHO). 2010. Cholera vaccines: WHO position 
paper. Wkly Epidemiol Rec 85:117-128. 
12. Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, Ahmed F, Rao 
MR, Khan MR, Yunus M, Huda N, et. al. 1990. Field trial of oral cholera 
vaccines in Bangladesh: results from three-year follow-up. Lancet 335:270-273. 
13. Trach DD, Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG, Hang PV, Rao 
MR. 1997. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. 
Lancet 349:231-235. 
14. Thiem VD, Deen JL, von Seidlein L, Canh DG, Anh DD, Park JK, Ali M, 
Danovaro-Holliday MC, Son ND, Hoa NT, Holmgren J, Clemens JD. 2006. 
Long-term effectiveness against cholera of oral killed whole-cell vaccine 
produced in Vietnam. Vaccine 24:4297-4303. 
15. Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Dialo AA, 
Itama C, Serafini M, Legros D, Grais RF. 2013. First outbreak response using 
an oral cholera vaccine in Africa: vaccine coverage, acceptability and 
surveillance of adverse events, Guinea, 2012. PLoS Negl Trop Dis 7(10):e2465. 
16. World Health Organization (WHO). 2014. Cholera, 2013. Wkly Epidemiol Rec 
89:345-356. 
17. Nelson EJ, Harris JB, Morris JG, Jr., Calderwood SB, Camilli A. 2009. 
Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev 
Microbiol 7:693-702. 
	  	  
35	  
18. Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, 
Calderwood SB, Qadri F, Harris JB. 2009. Clinical outcomes in household 
contacts of patients with cholera in Bangladesh. Clin Infect Dis 49:1473-1479. 
19. Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB. 1974. 
Response of man to infection with Vibrio cholerae. I. Clinical, serological, and 
bacteriologic responses to a known inoculum. J Infect Dis 129:45-52. 
20. Cash RA, Music SI, Libonati JP, Craig JP, Pierce NF, Hornick RB. 1974. 
Response of manto infection with Vibrio cholerae. II. Protection from illness 
afforded by previous disease and vaccine. J Infect Dis 129:325-333. 
21. Feachem RG. 1982. Environmental aspects of cholera epidemiology. III. 
Transmission and control. Trop Dis Bull 79:1-47. 
22. Kaper JB, Morris JG Jr, Levine MM. 1995. Cholera. Clin Microbiol Rev. 8:48-
86.  
23. Sack DA, Sack RB, Nair GB, Siddique AK. 2004. Cholera. Lancet 363:223-233 
24. Wachsmuth IK, Blake PA, Olsvik O. 1994. Vibrio cholerae to cholera: 
Molecular to global perspectives. ASM, Washington DC. 
25. Rosenberg CE. 1987. The cholera years: the United States in 1832, 1849, and 
1866. University of Chicago Press, Chicago.  
26. Barua D. 1972. The global epidemiology of cholera in recent years. Proc R Soc 
Med 65:423-428. 
27. Snow J, Frost W, Richardson B. 1936. Snow on cholera. New York: 
Commonwealth Fund. 
28. Bentivoglio M, Pacini P. 1995. Filippo Pacini: a determined observer. Brain Res 
Bull 38(2):161-165. 
	  	  
36	  
29. Koch R. 1884. An address on cholera and its bacillus. Br Med J 2:453-459 
30. Judicial Commission, International Committee on Bacteriological 
Nomenclature. 1965. Opinion. Int B Bact Nomencl 15:185. 
31. Gardner AD, Venkatraman KV. 1935. The antigens of the cholera group of 
vibrios. J Hyg 35:262-282. 
32. Shimada T, Arakawa E, Itoh, K, Okitsu T, Matsushima A, Asai, Y, Yamai S, 
Nakazato T, Nair GB, Albert MJ, Takeda Y. 1994. Extended serotyping for 
Vibrio cholerae. Curr Microbiol 28:175-178. 
33. Yamai S, Okitsu T, Shimada T, Katsube Y. 1997. Distribution of serogroups of 
Vibrio cholerae non-O1 non-O139 with specific reference to their ability to 
produce cholera toxin and addition of novel serogroups. Jpn J Infect Dis 
71:1037-1045. 
34. Siddique AK, Baqui AH, Eusof A, Haider K, Hossain MA, Bashir I, Zaman K. 
1991. Survivial of classical cholera in Bangladesh. Lancet 337:1125-1127. 
35. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, 
Takeda T, Karasawa T, Kurazano H, Pal A, et al. 1993. Emergence of novel 
strain of Vibrio cholerae with epidemic potential in southern and eastern India. 
Lancet 341:703-704. 
36. Albert MJ, Siddique AK, Islam MS, Faruque AS, Ansaruzzaman M, Faruque 
SM, Sack RB. 1993. Large outbreak of clinical cholera due to Vibrio cholerae 
non-O1 in Bangladesh. Lancet 341:704. 
37. Cholera Working Group, International Centre for Diarrhoeal Diseases 
Research, Bangladesh. 1993. Large epidemic of cholera-like disease in 
	  	  
37	  
Bangladesh caused by Vibrio cholerae O139 synonym Bangal. Lancet 342:387-
390. 
38. Faruque SM, Chowdhury N, Kamruzzaman Mm Ahmad QS, Faruque AS, 
Salam MA, Ramamurthy T, Nair GB, Weintraub A, Sack DA. 2003. 
Reemergence of epidemic Vibrio cholerae O139, Bangladesh. Emerg Infect Dis 
9:1116-1122. 
39. Nair G, Faruque SM, Bhuiyan NA, Kamruzzaman M, Siddique AK, Sack DA. 
2002. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the 
classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J 
Clin Microbiol 40:3296-3299. 
40. Nusrin S, Khan GY, Bhuiyan NA, Ansaruzzaman M, Hossain MA, Safa A, 
Khan R, Faruque SM, Sack DA, Hamabata T, Takeda Y, Nair GB. 2004. 
Diverse CTX phages among toxigenic Vibrio cholerae O1 and O139 strains 
isolated between 1994 and 2002 in an area where cholera is endemic in 
Bangladesh. J Clin Microbiol 42:5854-5856. 
41. Ghosh-Banerjee J, Senoh M, Takahashi T, Hamabata T, Barman S, Koley H, 
Mukhopadhyay AK, Ramamurthy T, Chatterjee S, Asakura M, Yamasaki S, 
Nair GB, Takeda Y. 2010. Cholera toxin production by the El Tor variant of 
Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J. Clin 
Microbiol 48:4283-4286. 
42. Ali M, Lopez AL, You YA, Kim YE, Sah B, Maskery B, Clemens J. 2012. The 
global burden of cholera. Bull World Health Organ 90:209-218A. 
43. Griffith DC, Kelly-Hope L, Miller M. 2006. Review of reported cholera outbreaks 
worldwide, 1995-2005. Am J Trop Med Hyg 75:973-977. 
	  	  
38	  
44. Ali A, Chen Y, Johnson JA, Redden E, Mayette Y, Rashid MH, Stine OC, 
Morris JG, Jr. 2011. Recent clonal origin of cholera in Haiti. Emerg Infect Dis 
17:699-701. 
45. Piarroux R, Barrais R, Faucher B, Haus R, Piarroux M, Gaudart J, Magloire 
R, Raoult D. 2011. Understanding the cholera epidemic, Haiti. Emerg Infect Dis 
17:1161-1168. 
46. Hendriksen RS, Price LB, Schupp JM, Gillece JD, Kaas RS, Engelthaler DM, 
Bortolaia V, Pearson T, Water AE, Upadhyay BP, Shrestha SD, Adhikari S, 
Shakya G, Keim PS, Aarestrup FM. 2011. Population genetics of Vibrio 
cholerae from Nepal in 2010: Evidence on the origin of the Haitian outbreak. 
MBio 2(4):e00157-11. 
47. Eppinger M, Pearson T, Koenig SS, Pearson O, Hicks N, Agrawal S, Sanjar 
F, Galens K, Daugherty S, Crabtree J, Hendriksen RE, Price LB, Upadhyay 
BP, Shakya G, Fraser CM, Ravel J, Keim PS. 2014. Genomic epidemiology of 
the Haitian cholera outbreak: a single introduction followed by rapid, extensive, 
and continued spread characterized the onset of the epidemic. MBio 
5(6):e01721-14. 
48. Pollitzer R, Swaroop S, Burrows W. 1959. Cholera. Monogr Ser World Health 
Organ 58:1001-1019. 
49. Pan American Health Organization. 2010. Cholera outbreak in Haiti. EOC 
situation report no. 6 
50. Centers for Disease Control and Prevention (CDC). 2010. Cholera outbreak – 
Haiti, October 2010. Morb Mort Wkly 59:1411. 
	  	  
39	  
51. Pan American Health Organization. 2010. Cholera outbreak in Haiti. EOC 
situation report no. 4 
52. Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, Dahourou GA, Mintz 
ED, Steenland MW, Vertefeuille JF, Tappero JW. 2013. Cholera surveillance 
during the Haiti epidemic – the first 2 years. N Engl J Med 368:599-609. 
53. Colwell RR, Kaper J, Joseph SW. 1977. Vibrio cholerae, Vibrio 
parahaemolyticus, and other vibrios: occurrence and distribution in Chesapeake 
Bay. Science 198:394-396. 
54. Colwell RR. 1996. Global climate and infectious disease: the cholera paradigm. 
Science 274:2025-2031. 
55. Islam MS, Drasar BS, Sack RB. 1994. The aquatic flora and fauna as reservoirs 
of Vibrio cholerae: a review. J Diarrh Dis 12:87-96. 
56. Hood MA, Ness GE, Rodrick GE. 1981. Isolation of Vibrio cholerae serotype O1 
form the eastern oyster, Crassostrea virginica. Appl Environ Microbiol 41:559-
560. 
57. Huq A, Small EB, West PA, Huq MI, Rahman R, Colwell RR. 1983. Ecological 
relationship between Vibrio cholerae and planktonic crustacean copepods. Appl 
Environ Microbiol 45:275-283. 
58. Tamplin ML, Gauzens AL, Huq A, Sack DA, Colwell RR. 1990. Attachment of 
Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh 
waters. Appl Environ Microbiol 56:1977-1980. 
59. Huq A, Colwell RR, Rahmann R, Ali A, Chowdhury MAR, Parveen S, Sack 
DA, Russek-Chohen R. 1990. Detection of Vibrio cholerae O1 in aquentic 
	  	  
40	  
environment by fluorescent-monoclonal antibody and culture methods. Appl 
Environ Microbiol 56:2370-2373. 
60. Halpern M, Broza YB, Mittler S, Arakawa E, Broza M. 2004. Chironomid egg 
masses as a natural reservoir of Vibrio cholerae non-O1 and non-O139 in 
freshwater habitats. Microb Ecol 47:341-349. 
61. Rawlings TK, Ruiz GM, Colwell RR.  2007. Association of Vibrio cholerae O1 El 
Tor and O139 Bengal with the Copepods Acartia tonsa and Eurytemora affinis. 
Appl Environ Microbiol 73:7926-7933. 
62. Huq A, Whitehouse CA, Grim CJ, Alam M, Colwell RR. 2008. Biofilms in 
water, its role and impact in human disease transmission. Curr Opin Biotech 
19:244-247. 
63. Colwell RR, Brayton PR, Grimes DJ, Roszak DR, Huq SA, Palmer LM. 1985. 
Viable, but non-culturable Vibrio cholerae and related pathogens in the 
environment: implications for the release of genetically engineered 
microoganisms. Bio/Technology 3:817-820. 
64. Xu HS, Roberts N, Singleton FL, Atwell RW, Grimes DJ, Colwell RR. 1982. 
Surivival and viability of non-culturable Escherichia coli and Vibrio cholerae in the 
estuarine and marine environment. Microb Ecol 8:313-323. 
65. Schlater LK, Blackburn BO, Harrington RJ, Draper DJ, Van Wagner J, David 
BR. 1981. A non-O1 Vibrio cholerae isolated from a goose. Avian Dis 25:199-
201. 
66. Ogg JE, Ryder RA, Smith HL. 1989. Isolation of Vibrio cholerae from aquatic 
birds in Colorado and Utah. Appl Environ Microbiol 55:95-99. 
	  	  
41	  
67. Buck JD. 1990. Isolation of Candida albicans and halophilic Vibrio spp. from 
aquatic birds in Connecticut and Florida. Appl Environ Microbiol 56:826-828. 
68. Frisch F, Green AJ, Figueola J. 2007. High dispersal capacity of a broad 
spectrum of aquatic invertebrates via waterbirds. Aquat Sci 69:568-574.  
69. Senderovich Y, Izhaki I, Halpern M. 2010. Fish as reservoirs and vectors of 
Vibrio cholerae. PLoS One 5:e8607. 
70. Runft DL, Mitchell KC, Abuaita BH, Allen JP, Bajer S, Ginsburg K, Neely 
MN, Withey JH. 2014. Zebrafish as a natural host model for Vibrio cholerae 
colonization and transmission. Appl Environ Microbiol 80:1710-1717. 
71. Traoré O, Martikainen O, Siitonen A, Traoré AS, Barro N, Haukka K. 2014. 
Occurrence of Vibrio cholerae in fish and water from a reservoir and a 
neighboring channel in Ouagadougou, Burkina Faso. J Infect Dev Ctries 8:1334-
1338. 
72. Halpern M, Senderovich Y, Izhaki I. 2008. Waterfowl – the missing link in 
epidemic and pandemic cholera dissemination? PLoS Pathog 4:e1000173. 
73. Vezzulli L, Pruzzo C, Huq A, Colwell RR. 2010. Environmental reservoirs of 
Vibrio cholerae and their role in cholera. Environ Microbiol Rep 2:27-33. 
74. Butler SM, Camilli A. 2005. Going against the grain: chemotaxis and infection in 
Vibrio cholerae. Nat Rev Microbiol 3:611-620. 
75. Krukonis ES, DiRita VJ. 2003. From motility to virulence: sensing and 
responding to environmental signals in Vibrio cholerae. Curr Opin Microbiol 
6:186-190. 
	  	  
42	  
76. Schrank GD, Verwey WF.  1976. Distribution of cholera organisms in 
experimental Vibrio cholerae infections: proposed mechanisms of pathogenesis 
and antibacterial immunity. Infect Immun 13:195-203. 
77. Holmgren J, Svennerholm AM. 1977. Mechanisms of disease and immunity in 
cholera: a review. J Infect Dis 136:S105-112. 
78. Millet YA, Alvarez D, Ringgaard S, Andrian von UH, Davis BM, Waldor MK. 
2014. Insights into Vibrio cholerae intestinal colonization from monitoring 
fluorescently labeled bacteria. PLoS Pathog 10:e1004405. 
79. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, Cohen MB, 
Calderwood SB, Schoolnik GK, Camilli A. 2002. Host-induced epidemic 
spread of the cholera bacterium. Nature 417:642-645. 
80. Nelson EJ, Chowdhury A, Flynn J, Schlid S, Bourassa L, Shao Y, LaRocque 
RC, Calderwood SB, Qadri F, Camilli A.  2008. Transmission of Vibrio cholerae 
is antagonized by lytic phage and entry into the aquatic environment. PLoS 
Pathog 4:e1000187. 
81. Alam M, Sultana M, Nair GB, Siddique AK, Hasan NA, Sack RB, Sack DA, 
Ahmed KU, Sadique A, Watanabe H, Grim CJ, Huq A, Colwell RR. 2007. 
Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic 
environment and their role in cholera transmission. Proc Natl Acad Sci USA 
104:17801-17806.  
82. Oliver JD.  2005. The viable but nonculturable state in bacteria. J Microbiol 
43:93-100. 
	  	  
43	  
83. Colwell RR, Brayton P, Herrington D, Tall B, Huq A, Levine MM. 1996. Viable 
but non-culturable Vibrio cholerae O1 revert to a cultivable state in the human 
intestine. World J Microbiol Biotechnol 12:28-31.  
84. Nalin DR, Daya V, Reid A, Levine MM, Cisneros L. 1979. Adsorption and 
growth of Vibrio cholerae on chitin. Infect Immun 25:768-770. 
85. Meibom KL, Li XB, Nielsen AT, Wu CY, Roseman S, Schoolnik GK. 2004. 
The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci USA 101:2524-
2529. 
86. Bartlett DH, Azam F. 2005. Microbiology. Chitin, cholera, and competence. 
Science 310:1775-1777. 
87. Matz C, McDougald D, Moreno AM, Yung PY, Yildiz FH, Kjelleberg S. 2005. 
Biofilm formation and phenotypic variation enhance predation-driven persistence 
of Vibrio cholerae. Proc Natl Acad Sci USA 102:16819-16824.  
88. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ. 1986. Identification of a pilus 
colonization factor that is coordinately regulated with cholera toxin. Ann Sclavo 
Collana Monogr 3:51-61. 
89. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ. 1987. Use of phoA gene 
fusion to identify a pilus colonization factor coordinately regulated with cholera 
toxin. Proc Natl Acad Sci USA 84:2833-2837.  
90. Waldor MK, Mekalanos JJ. 1996. Lysogenic conversion by a filamentous phage 
encoding cholera toxin. Science 272:1910-1914. 
91. Faruque SM, Albert MJ, Mekalanos JJ. 1998. Epidemiology, genetics, and 
ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 62:1301-1314. 
	  	  
44	  
92. Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, 
Kaper JB. 1991. Vibrio cholerae produced a second enterotoxin, which affects 
intestinal tight junctions. Proc Natl Acad Sci USA 88:5242-5246. 
93. Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. 1993. Accessory 
cholera enterotoxin (Ace), the third toxin of Vibrio cholerae virulence cassette. 
Proc Natl Acad Sci USA 90:5267-5271. 
94. Johnson JA, Morris JG, Jr., Kaper JB. 1993. Gene encoding zonula occudens 
toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in 
Vibrio cholerae. J Clin Microbiol 31:732-733. 
95. Finkelstein RA, LoSpalluto JJ. 1969. Pathogenesis of experimental cholera. 
Preparation and isolation of choleragen and choleragenoid. J Exp Med 130:185-
202. 
96. Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. 
1998. A Vibrio cholerae pathogenicity island associated with epidemic and 
pandemic strains. Proc Natl Acad Sci USA 95:3134-3139. 
97. Lonnroth I, Holmgren J. 1973. Subunit structure of cholera toxin. J Gen 
Microbiol 76:417-427. 
98. Gill DM. 1976. The arrangement of subunits in cholera toxin. Biochem 15:1242-
1248. 
99. Field M. 1979. Mechanisms of action of cholera and Escherichia coli 
enterotoxins. Am J Clin Nutr 32:189-196. 
100. Jodal Mal O. 1986. Enterotoxin-induced fluid secretion and the enteric nervous 
system, p.311 p. In Holmgren J, Lindberg A, Mollby R (ed.), Development of 
	  	  
45	  
vaccines and drugs against diarrhea: 11th Nobel Conference, Stockholm 1985. 
Studentlitteratur, Lund, Sweden. 
101. Field M, Fromm D, Al-Awqati Q, Greenough WB, III. 1972. Effect of cholera 
enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest 51:796-
804. 
102. Molla AM, Rahman M, Sarker SA, Sack DA, Molla A. 1981. Stool electrolyte 
content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, 
and V. cholerae in children. J Pediatr 98:835-838. 
103. Herrington DA, Hall RH, Losonski G, Mekalanos JJ, Taylor RK, Levine MM. 
1988. Toxin, toxin-coregulated pili and the toxR regulation are essential for Vibrio 
cholerae pathogenesis in humans. J Exp Med 168:1487-1492. 
104. Kirn TJ, Lafferty MJ, Sandoe CM, Taylor RK. 2000. Delineation of pilin 
domains required for bacterial association into microcolonies and intestinal 
colonization by Vibrio cholerae. Mol Microbiol 35:896-910. 
105. Yancey RJ, Berry LJ. 1978. Motility of the pathogen and intestinal immunity of 
the host in experimental cholera. Adv Exp Med Biol 107:447-455. 
106. Yancey RJ, Willis DL, Berry LJ. 1978. Role of motility in experimental cholera 
in adult rabbits. Infect Immun 22:387-392. 
107. Freter R, O’Brien PC. 1981. Role of chemotaxis in the association of motile 
bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio 
cholerae mutants in infant mice. Infect Immun 34:222-233. 
108. Freter R, O’Brien PC, Macsai MS. 1981. Role of chemotaxis in the association 
of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun 34:234-
240. 
	  	  
46	  
109. Richardson K. 1991. Roles of motility and flagellar structure in pathogenicity of 
Vibrio cholerae: analysis of motility mutants in three animal models. Infect Immun 
59:2727-2736. 
110. Smith RW, Koffler H. 1971. Bacterial flagella. Adv Microb Physiol 6:219-339. 
111. Atsumi T, McCarter LL, Imae Y. 1992. Polar and lateral flagellar motors of 
marine Vibrio are driven by different ion-motive forces. Nature 355:182-184. 
112. Asai Y, Kawagishi I, Sockett RE, Homma M. 2000. Coupling ion specificity of 
chimeras between H+- and Na+-driven motor proteins, MotB and PomB, in Vibrio 
polar flagella. EMBO J 19:3639-3648. 
113. Blair DF. 2003. Flagellar movement driven by proton translocations. FEBS Lett 
545:86-95.  
114. Berg HC. 2003. The rotary motor of bacterial flagella. Annu Rev Biochem 72:19-
54. 
115. Terashima H, Kojima S, Homma M. 2008. Flagellar motility in bacteria structure 
and function of flagellar motor. Int Rev Cell Mol Biol 270:39-85.  
116. Fukuoka H, Wada T, Kojima S, Ishijima A, Homma M. 2009. Sodium-
dependent dynamic assembly of membrane complexes in sodium-driven flagellar 
motors. Mol Microbiol 71:825-835. 
117. Aizawa SI. 1996. Flagellar assembly in Salmonella typhimurium. Mol Microbiol 
19:1-5.  
118. Terashima H, Fukuoka H, Yakushi T, Kojima S, Homma M. 2006. The Vibrio 
motor proteins, MotX and MotY, are associated with the basal body of Na+-driven 
flagella and required for stator formation. Mol Microbiol 62:1170-1180. 
	  	  
47	  
119. McCarter LL. 1994. MotX, the channel component of the sodium-type flagellar 
motor. J Bacteriol 176:5988-5998. 
120. McCarter LL. 1994. MotY, a component f the sodium-type flagellar motor. J 
Bacteriol 176:4219-4225. 
121. Okabe M, Yakushi T, Asai Y, Homma M.  2001. Cloning and characterization of 
motX, a Vibrio alginolyticus sodium-driven flagellar motor gene. J Biochem 
130:879-884. 
122. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, 
Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, 
Tettlin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, 
Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, 
White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, 
Fraser CM.  2000. DNA sequence of both chromosomes of the cholera pathogen 
Vibrio cholerae. Nature 406:477-483. 
123. Gosink KK, Kobayashi R, Kawagishi I, Hase CC. 2002. Analyses of the roles 
of the three cheA homologs in chemotaxis of Vibrio cholerae. J Bacteriol 
184:1767-1771. 
124. Boin M, Austin M, Hase C. 2004. Chemotaxis in Vibrio Cholerae. FEMS 
Microbiol Lett 239:1-8. 
125. Lee SH, Butler SM, Camilli A. 2000. Selection for in vivo regulators of bacterial 
virulence. Proc Natl Acad Sci USA 98:6889-6894. 
126. Baselski V, Briggs R, Parker C. 1977. Intestinal fluid accumulation induced by 
oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect Immun 
15:704-712. 
	  	  
48	  
127. Klose KE. 2000. The suckling mouse model of cholera. Trends Microbiol 8:189-
191. 
128. De SH, Chatterjee DN. 1953. An experimental study of the mechanisms of 
action of Vibrio cholerae on the intestinal mucous membrane. J Pathol Bacteriol 
46:559-562. 
129. Formal SB, Kundel D, Schneider H, Kunevn, Sprinz H. 1961. Studies with 
Vibrio cholerae in the ligated loop of the rabbit intestine. Br J Exp Pathol  42:504-
510. 
130. Spira WM, Sack RB, Froehlich JL. 1981. Simple adult rabbit model for Vibrio 
cholerae and exterotoxigenic Escherichia coli diarrhea. Infect Immun 32: 739-
747. 
131. Menke AL, Spitsbergen JM, Wolterbeek APM, Woutersen RA. 2011. Normal 
anatomy and histology of the adult zebrafish. Toxicol Pathol 39:759-775. 
132. Wallace KN, Akhter S, Smith EM, Lorent K, Pack M. 2005. Intestinal growth 
and differentiation in zebrafish. Mech Devel 122:157-173. 
133. Hyakutake A, Homma M, Kawagishi I. 2004. Effects of five CheY homologues 
of Vibrio cholerae on swimming behavior. ASM Abstracts 10:I-139. 
134. Hyakutake A, Homma M, Austin MJ, Boin MA, Hase CC, Kawagishi I. 2005. 
One one of the five CheY homologs in Vibrio cholerae directly switches flagellar 
rotation. J Bacteriol 187:8403-8410. 
135. Klose KE, Mekalanos JJ. 1998. Differential regulation of multiple flagellins in 
Vibrio cholerae. J Bacteriol 180:303-316. 
136. Zhu S, Kojima S, Homma M. 2013. Structure, gene regulation and 
environmental response of flagella in Vibrio. Front Microbiol 4:410. 
	  	  
49	  
137. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed 
mutagenesis by over extension using the polymerase chain reaction. Gene 
77:51-59. 
138. Atkinson MJ, Bingman C. 1997. Elemental composition of commercial seasalts. 
J Aquariculture Aquat 8:39-43. 
139. Biswas M, Dey S, Khamrui S, Sen U, Dasgupta J. 2013. Conformational 
barrier of CheY3 and inability of CheY4 to bind FliM control the flagellar motor 
action in Vibrio cholerae. PLoS One 8:e73923. 
140. Butler SM, Camilli A. 2004. Both chemotaxis and net motility greatly influence 
the infectivity of Vibrio cholerae. PNAS 101:5018-5023. 
141. Peterson BW, Sharma PK, van der Mei HC, Busscher HJ. 2011. Bacterial cell 
surface damage due to centrifugal compaction. Appl Environ Microbiol 78:120-
125. 
142. Pembrey RS, Marshall KC, Schneider RP. 1999. Cell surface analysis 
techniques: what do cell preparation protocols do to cell surface properties? Appl 
Environ Microbiol 65:2877-2894. 
 
  
	  	  
50	  
ABSTRACT 
THE EFFECTS OF MOTILITY AND CHEMOTAXIS 
ON VIBRIO CHOLERAE COLONIZATION IN ZEBRAFISH 
by 
PAULA RENE DIETZ 
August 2015 
Advisor: Dr. Jeff Withey 
Major: Immunology & Microbiology 
Degree: Master of Science 
 Vibrio cholerae, the cause of the diarrheal disease cholera, is a gram-negative, 
curved rod-shaped bacterium, with a single polar flagellum. V. cholerae is naturally 
found in aquatic environments and is highly motile. When it enters a human host, V. 
cholerae uses flagellar motility to pass through the stomach and into the small intestine. 
Once in the small intestine, motility genes are downregulated and virulence gene 
expression is upregulated. V. cholerae motility and chemotaxis effects have not yet 
been studied in a zebrafish model, a natural host of this bacterium. We hypothesize that 
V. cholerae in frame deletions of vital motility and chemotaxis proteins, such as flaA, 
cheY-3, and motY, would decrease the ability of V. cholerae to colonize the zebrafish 
intestine. However, the deletion of chemotaxis gene cheY-3 actually significantly 
increases the ability of V. cholerae to colonize the zebrafish intestine, and only the 
deletion of motility gene motY significantly decreases colonization compared to wild-
type.  
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